{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:33:51Z","timestamp":1794040431734,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22bm0804027h0003"],"award-info":[{"award-number":["22bm0804027h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19bm0804003"],"award-info":[{"award-number":["19bm0804003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20bm0804003"],"award-info":[{"award-number":["20bm0804003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21bm0804003"],"award-info":[{"award-number":["21bm0804003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20ek0109492"],"award-info":[{"award-number":["20ek0109492"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21ek0109492"],"award-info":[{"award-number":["21ek0109492"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ek0109492"],"award-info":[{"award-number":["22ek0109492"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is an inherited cerebral small vessel disease (CSVD) caused by biallelic mutations in the <jats:italic>high-temperature requirement serine peptidase A1 (HTRA1)<\/jats:italic> gene. Even heterozygous mutations in <jats:italic>HTRA1<\/jats:italic> are recently revealed to cause cardinal clinical features of CSVD. Here, we report the first establishment of a human induced pluripotent stem cell (hiPSC) line from a patient with heterozygous <jats:italic>HTRA1<\/jats:italic>-related CSVD. Peripheral blood mononuclear cells (PBMCs) were reprogrammed by the transfection of episomal vectors encoding human <jats:italic>OCT3\/4<\/jats:italic> (<jats:italic>POU5F1<\/jats:italic>), <jats:italic>SOX2<\/jats:italic>, <jats:italic>KLF4<\/jats:italic>, <jats:italic>L-MYC<\/jats:italic>, <jats:italic>LIN28<\/jats:italic>, and a murine dominant-negative mutant of <jats:italic>p53<\/jats:italic> (<jats:italic>mp53DD<\/jats:italic>). The established iPSCs had normal morphology as human pluripotent stem cells and normal karyotype (46XX). Moreover, we found that the <jats:italic>HTRA1<\/jats:italic> missense mutation (c.905G&gt;A, p.R302Q) was heterozygous. These iPSCs expressed pluripotency-related markers and had the potential to differentiate into all three germ layers in vitro. <jats:italic>HTRA1<\/jats:italic> and the supposed disease-associated gene <jats:italic>NOG<\/jats:italic> were differentially expressed in the patient iPSCs at mRNA levels compared to those of control lines. The iPSC line would facilitate in vitro research for understanding the cellular pathomechanisms caused by the <jats:italic>HTRA1<\/jats:italic> mutation including its dominant-negative effect.<\/jats:p>","DOI":"10.1186\/s41232-023-00273-7","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:28:53Z","timestamp":1680517733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a\u00a0heterozygous\u00a0R302Q mutation in HTRA1"],"prefix":"10.1186","volume":"43","author":[{"given":"Emi","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-5935","authenticated-orcid":false,"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"273_CR1","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1177\/0963689718795148","volume":"27","author":"Q Li","year":"2018","unstructured":"Li Q, Yang Y, Reis C, Tao T, Li W, Li X, et al. Cerebral small vessel disease. Cell Transplant. 2018;27:1711\u201322.","journal-title":"Cell Transplant."},{"key":"273_CR2","doi-asserted-by":"crossref","unstructured":"Fu Y, Yan Y. Emerging Role of Immunity in Cerebral Small Vessel Disease. Front Immunol. 2018;9:67.","DOI":"10.3389\/fimmu.2018.00067"},{"key":"273_CR3","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.neurobiolaging.2011.04.008","volume":"33","author":"RPW Rouhl","year":"2012","unstructured":"Rouhl RPW, Damoiseaux JGMC, Lodder J, Theunissen ROMFIH, Knottnerus ILH, Staals J, et al. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging. 2012;33:1800\u20136.","journal-title":"Neurobiol Aging"},{"key":"273_CR4","doi-asserted-by":"crossref","unstructured":"Zhang DD, Cao Y, Mu JY, Liu YM, Gao F, Han F, et al. Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study. Stroke Vasc Neurol. 2022;7:302\u20139.","DOI":"10.1136\/svn-2021-001102"},{"key":"273_CR5","doi-asserted-by":"crossref","unstructured":"Low A, Mak E, Rowe JB, Markus HS, O\u2019Brien JT. Inflammation and cerebral small vessel disease: a systematic review. Ageing Res Rev. 2019;53:100916.","DOI":"10.1016\/j.arr.2019.100916"},{"key":"273_CR6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1056\/NEJMoa0801560","volume":"360","author":"K Hara","year":"2009","unstructured":"Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med. 2009;360:1729\u201339.","journal-title":"N Engl J Med"},{"key":"273_CR7","doi-asserted-by":"crossref","unstructured":"Kato T, Manabe RI, Igarashi H, Kametani F, Hirokawa S, Sekine Y, et al. Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model. J Clin Invest. 2021;131:e140555.","DOI":"10.1172\/JCI140555"},{"key":"273_CR8","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1212\/WNL.0000000000002694","volume":"86","author":"H Nozaki","year":"2016","unstructured":"Nozaki H, Kato T, Nihonmatsu M, Saito Y, Mizuta I, Noda T, et al. Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology. 2016;86:1964\u201374.","journal-title":"Neurology"},{"key":"273_CR9","doi-asserted-by":"crossref","unstructured":"Uemura M, Nozaki H, Kato T, Koyama A, Sakai N, Ando S, et al. HTRA1-related cerebral small vessel disease: a review of the literature. Front Neurol. 2020;11:545.","DOI":"10.3389\/fneur.2020.00545"},{"key":"273_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/CM9.0000000000001176","volume":"134","author":"JY Liu","year":"2020","unstructured":"Liu JY, Zhu YC, Zhou LX, Wei YP, Mao CH, Cui LY, et al. HTRA1-related autosomal dominant cerebral small vessel disease. Chin Med J (Engl). 2020;134:178\u201384.","journal-title":"Chin Med J (Engl)"},{"key":"273_CR11","doi-asserted-by":"crossref","unstructured":"Uemura M, Nozaki H, Koyama A, Sakai N, Ando S, Kanazawa M, et al. HTRA1 mutations identified in symptomatic carriers have the property of interfering the trimer-dependent activation cascade. Front Neurol. 2019;10:693.","DOI":"10.3389\/fneur.2019.00693"},{"key":"273_CR12","doi-asserted-by":"crossref","unstructured":"Okano H, Yamanaka S. iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain. 2014;7:22.","DOI":"10.1186\/1756-6606-7-22"},{"key":"273_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27:523\u201331.","journal-title":"Cell Stem Cell"},{"key":"273_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","volume":"29","author":"H Okano","year":"2022","unstructured":"Okano H, Morimoto S. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. Cell Stem Cell. 2022;29:189\u2013208.","journal-title":"Cell Stem Cell"},{"key":"273_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"273_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"273_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.1172482","volume":"324","author":"Y Junying","year":"2009","unstructured":"Junying Y, Kejin H, Kim SO, Shulan T, Stewart R, Slukvin II, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324:797\u2013801.","journal-title":"Science"},{"key":"273_CR18","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1182\/blood-2009-02-204800","volume":"113","author":"YH Loh","year":"2009","unstructured":"Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, et al. Generation of induced pluripotent stem cells from human blood. Blood. 2009;113:5476\u20139.","journal-title":"Blood"},{"key":"273_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/stem.1293","volume":"31","author":"K Okita","year":"2013","unstructured":"Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2013;31:458\u201366.","journal-title":"Stem Cells"},{"key":"273_CR20","doi-asserted-by":"crossref","unstructured":"Nakagawa M, Taniguchi Y, Senda S, Takizawa N, Ichisaka T, Asano K, et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep. 2014;4:3594.","DOI":"10.1038\/srep03594"},{"key":"273_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107502","volume":"223","author":"S Kitahara","year":"2022","unstructured":"Kitahara S, Tsuboguchi S, Uemura M, Nozaki H, Kanazawa M, Onodera O. Patients with heterozygous HTRA1-related cerebral small vessel disease misdiagnosed with other diseases: two case reports. Clin Neurol Neurosurg. 2022;223: 107502.","journal-title":"Clin Neurol Neurosurg"},{"key":"273_CR22","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1172\/JCI3459","volume":"102","author":"E Gazzerro","year":"1998","unstructured":"Gazzerro E, Gangji V, Canalis E. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest. 1998;102:2106\u201314.","journal-title":"J Clin Invest"},{"key":"273_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/383707a0","volume":"383","author":"A Joutel","year":"1996","unstructured":"Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707\u201310.","journal-title":"Nature"},{"key":"273_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-018-1853-8","volume":"136","author":"A Zellner","year":"2018","unstructured":"Zellner A, Scharrer E, Arzberger T, Oka C, Domenga-Denier V, Joutel A, et al. CADASIL brain vessels show a HTRA1 loss-of-function profile. Acta Neuropathol. 2018;136:111\u201325.","journal-title":"Acta Neuropathol"},{"key":"273_CR25","doi-asserted-by":"crossref","unstructured":"Yamamoto Y, Kojima K, Taura D, Sone M, Washida K, Egawa N, et al. Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease. Mol Brain. 2020;13:38.","DOI":"10.1186\/s13041-020-00573-w"},{"key":"273_CR26","doi-asserted-by":"crossref","unstructured":"Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, Hayakawa H, et al. Mitochondrial dysfunction associated with increased oxidative stress and \u03b1-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain. 2012;5:35.","DOI":"10.1186\/1756-6606-5-35"},{"key":"273_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8:409\u201312.","journal-title":"Nat Methods"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-023-00273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-023-00273-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-023-00273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:39:49Z","timestamp":1680518389000},"score":1,"resource":{"primary":{"URL":"https:\/\/inflammregen.biomedcentral.com\/articles\/10.1186\/s41232-023-00273-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1186\/s41232-023-00273-7","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"6 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior informed and written consent was obtained from the patient to Niigata University. The study was approved by the Ethics Committee of Niigata University (approval no. G2017-0031) and Keio University (approval no. 20080016) regarding all experimental procedures, including blood sampling from the donor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H.O. is a scientific advisory board of San Bio Co., Ltd. and K Pharma Inc. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}